Dihydrocodeine Tartrate
| Grade | Pharmaceutical |
| Pharmacopoeia | USP, BP |
| CAS No. | 5965-13-9 |
| Product Name | Dihydrocodeine Tartrate |
| Chemical Name | 4,5α-Epoxy-3-methoxy-17-methylmorphinan-6α-ol hydrogen (2R,3R)-2,3-dihydroxybutanedioate |
| Function | Active Pharmaceutical Ingredients (APIs) |
| Industrial Application | Pharmaceutical |
| Category | Pain management |
General Description
Dihydrocodeine is an opioid analgesic agent used for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Physical Characteristics
| Molecular formula | C₂₂H₂₉NO₉ |
| Molecular weight | 451.5 |
| Appearance | White or almost white, crystalline powder |
| Solubility | Freely soluble in water, sparingly soluble in alcohol, practically insoluble in cyclohexane |
| Water | Maximum 0.7% |
| Specific optical rotation | -70.5 to -73.5 (anhydrous substance) |
| Sulfated ash | Maximum 0.1% |
| pH | 3.2 to 4.2 |
| Purity | Minimum 99.0% |
| Assay | 98.5% to 101.0% (anhydrous substance) |
| Storage | Protected from light |
| Stability | Stable at least 2 years at room temperature |